Zhi-Hong Yang1, Scott M Gordon1, Denis Sviridov1, Shuibang Wang2, Robert L Danner2, Milton Pryor1, Boris Vaisman1, Yuka Shichijo1, Nobushige Doisaki3, Alan T Remaley4. 1. Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892-1666, USA. 2. Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD 20892-1666, USA. 3. Tsukuba Plant, Nippon Suisan Kaisha, 7, Okubo, Tsukuba-shi, Ibaraki 300-2611, Japan. 4. Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892-1666, USA. Electronic address: aremaley1@nhlbi.nih.gov.
Abstract
BACKGROUND AND AIMS: Concentrated fish oils, containing a mixture of long-chain monounsaturated fatty acids (LCMUFA) with aliphatic chains longer than 18 C atoms (i.e., C20:1 and C22:1), have been shown to attenuate atherosclerosis development in mouse models. It is not clear, however, how individual LCMUFA isomers may act on atherosclerosis. METHODS: In the present study, we used saury fish oil-derived concentrates enriched in either C20:1 or C22:1 isomer fractions to investigate their individual effect on atherosclerosis and lipoprotein metabolism. LDLR-deficient (LDLr-/-) mice were fed a Western diet supplemented with 5% (w/w) of either C20:1 or C22:1 concentrate for 12 wk. RESULTS: Compared to the control Western diet with no supplement, both LCMUFA isomers increased hepatic levels of LCMUFA by 2∼3-fold (p < 0.05), and decreased atherosclerotic lesion areas by more than 40% (p < 0.05), although there were no major differences in plasma lipoproteins or hepatic lipid content. Both LCMUFA isomers significantly decreased plasma CRP levels, improved Abca1-dependent cholesterol efflux capacity of apoB-depleted plasma, and enhanced Ppar transcriptional activities in HepG2 cells. LC-MS/MS proteomic analysis of lipoproteins (HDL, LDL and VLDL) revealed that both LCMUFA isomer diets resulted in similar potentially beneficial alterations in proteins involved in complement activation, blood coagulation, and lipid metabolism. Several lipoprotein proteome changes were significantly correlated with atherosclerotic plaque reduction. CONCLUSIONS: Dietary supplementation with the LCMUFA isomers C20:1 or C22:1 was equally effective in reducing atherosclerosis in LDLr-/-mice and this may partly occur through activation of the Ppar signaling pathways and favorable alterations in the proteome of lipoproteins. Published by Elsevier B.V.
BACKGROUND AND AIMS: Concentrated fish oils, containing a mixture of long-chain monounsaturated fatty acids (LCMUFA) with aliphatic chains longer than 18 C atoms (i.e., C20:1 and C22:1), have been shown to attenuate atherosclerosis development in mouse models. It is not clear, however, how individual LCMUFA isomers may act on atherosclerosis. METHODS: In the present study, we used sauryfish oil-derived concentrates enriched in either C20:1 or C22:1 isomer fractions to investigate their individual effect on atherosclerosis and lipoprotein metabolism. LDLR-deficient (LDLr-/-)mice were fed a Western diet supplemented with 5% (w/w) of either C20:1 or C22:1 concentrate for 12 wk. RESULTS: Compared to the control Western diet with no supplement, both LCMUFA isomers increased hepatic levels of LCMUFA by 2∼3-fold (p < 0.05), and decreased atherosclerotic lesion areas by more than 40% (p < 0.05), although there were no major differences in plasma lipoproteins or hepatic lipid content. Both LCMUFA isomers significantly decreased plasma CRP levels, improved Abca1-dependent cholesterol efflux capacity of apoB-depleted plasma, and enhanced Ppar transcriptional activities in HepG2 cells. LC-MS/MS proteomic analysis of lipoproteins (HDL, LDL and VLDL) revealed that both LCMUFA isomer diets resulted in similar potentially beneficial alterations in proteins involved in complement activation, blood coagulation, and lipid metabolism. Several lipoprotein proteome changes were significantly correlated with atherosclerotic plaque reduction. CONCLUSIONS: Dietary supplementation with the LCMUFA isomers C20:1 or C22:1 was equally effective in reducing atherosclerosis in LDLr-/-mice and this may partly occur through activation of the Ppar signaling pathways and favorable alterations in the proteome of lipoproteins. Published by Elsevier B.V.
Authors: Chisa Matsumoto; Nirupa R Matthan; Alice H Lichtenstein; J Michael Gaziano; Luc Djoussé Journal: Am J Clin Nutr Date: 2013-07-03 Impact factor: 7.045
Authors: Michael H Davidson; Christie M Ballantyne; Terry A Jacobson; Vera A Bittner; Lynne T Braun; Alan S Brown; W Virgil Brown; William C Cromwell; Ronald B Goldberg; James M McKenney; Alan T Remaley; Allan D Sniderman; Peter P Toth; Sotirios Tsimikas; Paul E Ziajka; Kevin C Maki; Mary R Dicklin Journal: J Clin Lipidol Date: 2011 Sep-Oct Impact factor: 4.766
Authors: Shuibang Wang; Keytam S Awad; Jason M Elinoff; Edward J Dougherty; Gabriela A Ferreyra; Jennifer Y Wang; Rongman Cai; Junfeng Sun; Anetta Ptasinska; Robert L Danner Journal: J Biol Chem Date: 2015-06-23 Impact factor: 5.157
Authors: Daniel Seung Kim; Sean K Maden; Amber A Burt; Jane E Ranchalis; Clement E Furlong; Gail P Jarvik Journal: Lipids Health Dis Date: 2013-12-12 Impact factor: 3.876
Authors: Zhi-Hong Yang; Marcelo Amar; Alexander V Sorokin; James Troendle; Amber B Courville; Maureen Sampson; Martin P Playford; Shanna Yang; Michael Stagliano; Clarence Ling; Kwame Donkor; Robert D Shamburek; Nehal N Mehta; Alan T Remaley Journal: J Clin Lipidol Date: 2019-10-31 Impact factor: 4.766
Authors: Babunageswararao Kanuri; Vincent Fong; April Haller; David Y Hui; Shailendra B Patel Journal: BMC Med Genet Date: 2020-11-23 Impact factor: 2.103